Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Advances in immunotherapy for triple-negative breast cancer
Yang Liu, Yueting Hu, Jinqi Xue, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 123
Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy
Zili Zhang, Haifeng Zhou, Xiaohu Ouyang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 93
STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems
Hitesh Vasiyani, Bhumika Wadhwa
Cellular Signalling (2025), pp. 111647-111647
Closed Access | Times Cited: 3
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 34
Self-assembled albumin nanoparticles induce pyroptosis for photodynamic/photothermal/immuno synergistic therapies in triple-negative breast cancer
Jianquan Yang, Wen Guo, Rong Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Promoting the Recruitment, Engagement, and Reinvigoration of Effector T Cells via an Injectable Hydrogel with a Supramolecular Binding Capability for Cancer Immunotherapy
Yueqiang Zhu, Liangjie Jin, Junbin Chen, et al.
Advanced Materials (2023) Vol. 35, Iss. 47
Open Access | Times Cited: 23
Regulation of cGAS-STING signalling in cancer: Approach for combination therapy
Hitesh Vasiyani, Bhumika Wadhwa, Rajesh Singh
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188896-188896
Closed Access | Times Cited: 20
Research hotspots and frontiers of neoadjuvant therapy in triple-negative breast cancer: a bibliometric analysis of publications between 2002 and 2023
Chuang Yang, Hui Liu, Xing Feng, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 7
Targeting the stimulator of interferon genes (STING) in breast cancer
MA Ying-rui, Bai Bu-Fan, Liu Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I
Haiyan Dong, Chuangyu Wen, Lu He, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 3
Nano-STING agonist-decorated microrobots boost innate and adaptive anti-tumor immunity
Yixin Wang, Zhaoting Li, Yu Chen, et al.
Nano Research (2023) Vol. 16, Iss. 7, pp. 9848-9858
Closed Access | Times Cited: 8
Dendritic polylysine co-delivery of paclitaxel and siAXL enhances the sensitivity of triple-negative breast cancer chemotherapy
Xiaofeng Wan, Chuanrong Chen, Jianmin Zhan, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
Induced Ferroptosis Pathway by Regulating Cellular Lipid Peroxidation With Peroxynitrite Generator for Reversing “Cold” Tumors
Ruipeng Li, Haitao Yuan, Chuangxin Zhang, et al.
Small (2024)
Closed Access | Times Cited: 2
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Zijie Guo, Ziyu Zhu, Xixi Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Receptor-Based Strategies for Overcoming Resistance in Cancer Therapy
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
YTHDF1 shapes “cold” tumor and inhibits CD8+ T cells infiltration and function in breast cancer
Lanyu Jing, Kaiwen Zhou, Zilin Wang, et al.
Experimental Cell Research (2023) Vol. 432, Iss. 2, pp. 113778-113778
Closed Access | Times Cited: 2
Loss of STING impairs lactogenic differentiation
Ramiah R. Vickers, Garhett L. Wyatt, Lilia Sanchez, et al.
Development (2024) Vol. 151, Iss. 19
Open Access
Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer
Jiali Zhang, Bin Liu, Minchao Lyu, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 3, pp. 169-173
Open Access | Times Cited: 1
Breast cancer intrinsic YTHDF1 forms “cold” tumor and inhibits CD8+ T cells infiltration and function
Lanyu Jing, Kaiwen Zhou, Zilin Wang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top